November 2021 - 4D Lifetest™ Prostate Dx receive CE-IVD certification

Cancers of lung, breast, colon, and prostate account for approximately 60-70% of all cancers occurring annually. With the CE-IVD certification of our four liquid biopsy assays for exactly these types of cancers, we are now in a position to provide the vast majority of cancer patients in Europe with this much-needed help in early detection.